Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications

by Minoru Kidokoro, Hisatoshi Shida
Published 2014-10-01

A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells

by Yalçın Pısıl ⊃⊃, Hisatoshi Shida, Tomoyuki Miura
Published 2021-02-01

Is SARS-CoV-2 Neutralized More Effectively by IgM and IgA than IgG Having the Same Fab Region?

by Yalcin Pisil, Zafer Yazici, Hisatoshi Shida, Tomoyuki Miura
Published 2021-06-01

Specific Substitutions in Region V2 of gp120 <i>env</i> confer SHIV Neutralisation Resistance

by Yalcin Pisil, Zafer Yazici, Hisatoshi Shida, Shuzo Matsushita, Tomoyuki Miura
Published 2020-03-01

Combined Cytolytic Effects of a Vaccinia Virus Encoding a Single Chain Trimer of MHC-I with a Tax-Epitope and Tax-Specific CTLs on HTLV-I-Infected Cells in a Rat Model

by Takashi Ohashi, Takafumi Nakamura, Minoru Kidokoro, Xianfeng Zhang, Hisatoshi Shida
Published 2014-01-01

Elicitation of both anti HIV-1 Env humoral and cellular immunities by replicating vaccinia prime Sendai virus boost regimen and boosting by CD40Lm.

by Xianfeng Zhang, Tomoyoshi Sobue, Mao Isshiki, Shun-ichi Makino, Makoto Inoue, Kazunori Kato, Tatsuo Shioda, Takashi Ohashi, Hirotaka Sato, Jun Komano, Hideji Hanabusa, Hisatoshi Shida
Published 2012-01-01